scholarly journals Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement

2009 ◽  
Vol 101 (7) ◽  
pp. 1137-1144 ◽  
Author(s):  
C S Foster ◽  
◽  
A R Dodson ◽  
L Ambroisine ◽  
G Fisher ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Outcome ◽  
Gene Rearrangement ◽  
Poor Clinical Outcome ◽  
Hsp 27

Claspin Overexpression Promotes Tumor Progression and Predicts Poor Clinical Outcome in Prostate Cancer

2021 ◽  
Vol 25 (2) ◽  
pp. 131-139 ◽  
Author(s):  
Chao Cai ◽  
Jiexin Luo ◽  
Qinwei Liu ◽  
Zezhen Liu ◽  
Yan Zhao ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Outcome ◽  
Tumor Progression ◽  
Poor Clinical Outcome

Phosphorylation of Akt (Ser473) is an Excellent Predictor of Poor Clinical Outcome in Prostate Cancer

2004 ◽  
Vol 64 (15) ◽  
pp. 5232-5236 ◽  
Author(s):  
Jeffrey I. Kreisberg ◽  
Shazli N. Malik ◽  
Thomas J. Prihoda ◽  
Roble G. Bedolla ◽  
Dean A. Troyer ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Outcome ◽  
Poor Clinical Outcome

scholarly journals TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer

2008 ◽  
Vol 99 (11) ◽  
pp. 1849-1858 ◽  
Author(s):  
J F Knight ◽  
C J Shepherd ◽  
S Rizzo ◽  
D Brewer ◽  
S Jhavar ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Outcome ◽  
Basal Cell ◽  
Poor Clinical Outcome ◽  
Cell Markers
Sign in / Sign up

Export Citation Format

Share Document